ICARES Medicus, Inc. (TPEX:6612)

Market Cap	4.15B
Revenue (ttm)	1.08B
Net Income (ttm)	94.26M
Shares Out	46.83M
EPS (ttm)	2.00
PE Ratio	44.24
Forward PE	n/a
Dividend	0.27 (0.31%)
Ex-Dividend Date	Aug 22, 2025

Volume	35,657
Average Volume	32,993
Open	89.40
Previous Close	91.00
Day's Range	88.20 - 89.90
52-Week Range	80.45 - 131.36
Beta	0.38
RSI	40.64
Earnings Date	Nov 11, 2025

About ICARES Medicus

ICARES Medicus, Inc., together with its subsidiaries, engages in the design, research, development, manufacture, and sale of intraocular lenses and nanomedical devices in Taiwan, the United States, England, Japan, Spain, China, and internationally. The company offers ophthalmic medical devices, including intraocular lens for the treatment of cataract, myopia, hyperopia, presbyopia, and astigmatism; and surgical implant systems, as well as related technical services. It also provides nanomedical lubricious coatings and various surface treatments...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2011
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6612

Financial Performance

In 2024, ICARES Medicus's revenue was 859.79 million, an increase of 42.01% compared to the previous year's 605.45 million. Earnings were 103.12 million, an increase of 5.52%.